| Net Cash Provided by (Used in) Operating Activities |
$12,491 |
USD |
-44% |
Q3 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$18,782 |
USD |
60% |
Q3 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$0 |
USD |
|
Q3 2024 |
Q1 2025 |
| Common Stock, Shares Authorized |
100,000,000 |
shares |
0% |
Q4 2024 |
Q2 2025 |
| Common Stock, Shares, Issued |
11,208,000 |
shares |
0% |
Q4 2024 |
Q2 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q4 2024 |
Q2 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$935 |
USD |
-79% |
Q4 2024 |
Q2 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$0 |
USD |
|
Q3 2024 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$1,946 |
USD |
-28% |
Q3 2024 |
Q1 2025 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
24% |
Q3 2024 |
Q1 2025 |
| Deferred Tax Assets, Gross |
$11,198 |
USD |
1.4% |
Q1 2024 |
Q3 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$53,326 |
USD |
1.5% |
Q1 2024 |
Q3 2024 |
| Additional Paid in Capital |
$160,325 |
USD |
54% |
Q4 2024 |
Q2 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q1 2024 |
Q3 2024 |